Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes

10.1371/journal.pone.0104271

Saved in:

Bibliographic Details
Main Authors:	Gordon R.R., Wu M., Huang C.-Y., Harris W.P., Sim H.G., Lucas J.M., Coleman I., Higano C.S., Gulati R., True L.D., Vessella R., Lange P.H., Garzotto M., Beer T.M., Nelson P.S.
Other Authors:	SURGERY
Format:	Article
Published:	2019
Subjects:	amine oxidase (flavin containing) isoenzyme A clorgyline docetaxel hypoxia inducible factor 1alpha mitoxantrone amine oxidase (flavin containing) antineoplastic agent HIF1A protein, human monoamine oxidase A, human taxoid tumor protein animal experiment animal model animal tissue apoptosis Article cancer adjuvant therapy cancer recurrence cell survival controlled clinical trial controlled study drug cytotoxicity drug dose escalation drug effect drug potentiation drug resistance drug response enzyme activity gene expression gene identification genetic transcription human human cell human tissue in vitro study in vivo study major clinical study male mouse multiple cycle treatment nonhuman phase 1 clinical trial phase 2 clinical trial prostate carcinoma prostatectomy protein expression treatment outcome adult animal biosynthesis clinical trial drug effects enzymology gene expression regulation metabolism middle aged pathology Prostatic Neoplasms SCID mouse tumor cell line Adult Animals Antineoplastic Combined Chemotherapy Protocols Cell Line, Tumor Cell Survival Drug Resistance Gene Expression Regulation, Enzymologic Gene Expression Regulation, Neoplastic Humans Hypoxia-Inducible Factor 1, alpha Subunit Male Mice Mice, SCID Middle Aged Mitoxantrone Monoamine Oxidase Neoplasm Proteins Prostatectomy Taxoids
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/161775
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-161775
record_format	dspace
spelling	sg-nus-scholar.10635-1617752024-11-11T00:00:28Z Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes Gordon R.R. Wu M. Huang C.-Y. Harris W.P. Sim H.G. Lucas J.M. Coleman I. Higano C.S. Gulati R. True L.D. Vessella R. Lange P.H. Garzotto M. Beer T.M. Nelson P.S. SURGERY amine oxidase (flavin containing) isoenzyme A clorgyline docetaxel hypoxia inducible factor 1alpha mitoxantrone amine oxidase (flavin containing) antineoplastic agent docetaxel HIF1A protein, human hypoxia inducible factor 1alpha mitoxantrone monoamine oxidase A, human taxoid tumor protein animal experiment animal model animal tissue apoptosis Article cancer adjuvant therapy cancer recurrence cell survival controlled clinical trial controlled study drug cytotoxicity drug dose escalation drug effect drug potentiation drug resistance drug response enzyme activity gene expression gene identification genetic transcription human human cell human tissue in vitro study in vivo study major clinical study male mouse multiple cycle treatment nonhuman phase 1 clinical trial phase 2 clinical trial prostate carcinoma prostatectomy protein expression treatment outcome adult animal biosynthesis clinical trial drug effects enzymology gene expression regulation metabolism middle aged pathology Prostatic Neoplasms SCID mouse tumor cell line Adult Animals Antineoplastic Combined Chemotherapy Protocols Cell Line, Tumor Cell Survival Drug Resistance Gene Expression Regulation, Enzymologic Gene Expression Regulation, Neoplastic Humans Hypoxia-Inducible Factor 1, alpha Subunit Male Mice Mice, SCID Middle Aged Mitoxantrone Monoamine Oxidase Neoplasm Proteins Prostatectomy Prostatic Neoplasms Taxoids 10.1371/journal.pone.0104271 PLoS ONE 9 9 e104271 2019-11-07T05:08:03Z 2019-11-07T05:08:03Z 2014 Article Gordon R.R., Wu M., Huang C.-Y., Harris W.P., Sim H.G., Lucas J.M., Coleman I., Higano C.S., Gulati R., True L.D., Vessella R., Lange P.H., Garzotto M., Beer T.M., Nelson P.S. (2014). Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes. PLoS ONE 9 (9) : e104271. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0104271 19326203 https://scholarbank.nus.edu.sg/handle/10635/161775 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20191101
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	amine oxidase (flavin containing) isoenzyme A clorgyline docetaxel hypoxia inducible factor 1alpha mitoxantrone amine oxidase (flavin containing) antineoplastic agent docetaxel HIF1A protein, human hypoxia inducible factor 1alpha mitoxantrone monoamine oxidase A, human taxoid tumor protein animal experiment animal model animal tissue apoptosis Article cancer adjuvant therapy cancer recurrence cell survival controlled clinical trial controlled study drug cytotoxicity drug dose escalation drug effect drug potentiation drug resistance drug response enzyme activity gene expression gene identification genetic transcription human human cell human tissue in vitro study in vivo study major clinical study male mouse multiple cycle treatment nonhuman phase 1 clinical trial phase 2 clinical trial prostate carcinoma prostatectomy protein expression treatment outcome adult animal biosynthesis clinical trial drug effects enzymology gene expression regulation metabolism middle aged pathology Prostatic Neoplasms SCID mouse tumor cell line Adult Animals Antineoplastic Combined Chemotherapy Protocols Cell Line, Tumor Cell Survival Drug Resistance Gene Expression Regulation, Enzymologic Gene Expression Regulation, Neoplastic Humans Hypoxia-Inducible Factor 1, alpha Subunit Male Mice Mice, SCID Middle Aged Mitoxantrone Monoamine Oxidase Neoplasm Proteins Prostatectomy Prostatic Neoplasms Taxoids
spellingShingle	amine oxidase (flavin containing) isoenzyme A clorgyline docetaxel hypoxia inducible factor 1alpha mitoxantrone amine oxidase (flavin containing) antineoplastic agent docetaxel HIF1A protein, human hypoxia inducible factor 1alpha mitoxantrone monoamine oxidase A, human taxoid tumor protein animal experiment animal model animal tissue apoptosis Article cancer adjuvant therapy cancer recurrence cell survival controlled clinical trial controlled study drug cytotoxicity drug dose escalation drug effect drug potentiation drug resistance drug response enzyme activity gene expression gene identification genetic transcription human human cell human tissue in vitro study in vivo study major clinical study male mouse multiple cycle treatment nonhuman phase 1 clinical trial phase 2 clinical trial prostate carcinoma prostatectomy protein expression treatment outcome adult animal biosynthesis clinical trial drug effects enzymology gene expression regulation metabolism middle aged pathology Prostatic Neoplasms SCID mouse tumor cell line Adult Animals Antineoplastic Combined Chemotherapy Protocols Cell Line, Tumor Cell Survival Drug Resistance Gene Expression Regulation, Enzymologic Gene Expression Regulation, Neoplastic Humans Hypoxia-Inducible Factor 1, alpha Subunit Male Mice Mice, SCID Middle Aged Mitoxantrone Monoamine Oxidase Neoplasm Proteins Prostatectomy Prostatic Neoplasms Taxoids Gordon R.R. Wu M. Huang C.-Y. Harris W.P. Sim H.G. Lucas J.M. Coleman I. Higano C.S. Gulati R. True L.D. Vessella R. Lange P.H. Garzotto M. Beer T.M. Nelson P.S. Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes
description	10.1371/journal.pone.0104271
author2	SURGERY
author_facet	SURGERY Gordon R.R. Wu M. Huang C.-Y. Harris W.P. Sim H.G. Lucas J.M. Coleman I. Higano C.S. Gulati R. True L.D. Vessella R. Lange P.H. Garzotto M. Beer T.M. Nelson P.S.
format	Article
author	Gordon R.R. Wu M. Huang C.-Y. Harris W.P. Sim H.G. Lucas J.M. Coleman I. Higano C.S. Gulati R. True L.D. Vessella R. Lange P.H. Garzotto M. Beer T.M. Nelson P.S.
author_sort	Gordon R.R.
title	Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes
title_short	Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes
title_full	Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes
title_fullStr	Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes
title_full_unstemmed	Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes
title_sort	chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes
publishDate	2019
url	https://scholarbank.nus.edu.sg/handle/10635/161775
_version_	1821188925432004608

Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes

Similar Items